Doctors Offer Vaccine Insights as New Boosters are Readied
Santa Ana, CA, September 28, 2022 — Another COVID booster is on the horizon — this one targeting the BA.4 and BA.5 variants — opening the door for more discussion surrounding vaccine efficacy and the overall pandemic response.
Pointing to animal studies that date back more than 20 years, Dr. George Fareed of the Imperial Valley in California recently shared his perspective on why the type of vaccines being used have fallen short of expectations and possibly prolonged the pandemic.
“If you immunize a population in the pandemic with a vaccine that suppresses, to some extent, replication or gives some mild benefit of some sort in terms of the severity of the illness, it’s not a safe thing to do,” Dr. Fareed said. “You always use a blocking or a sterilizing vaccine — one that doesn’t allow the virus to break through. And that’s absolutely what we did not accomplish with these gene therapy-type vaccines … it doesn’t provide immunity or even prevent the infection for more than a few weeks or months … so it allows for a mutable virus to generate variants and perpetuate a pandemic.”
In the early days of COVID-19, Dr. Fareed and Dr. Brian Tyson created an early treatment protocol comprised of both pharmaceuticals and nutraceuticals. To date, they have successfully treated 12,000 COVID patients (and counting).
In their book, Overcoming the COVID Darkness, Drs. Fareed and Tyson chronicle their journey, detailing (in layperson’s terms) their COVID treatment formula and attempting to provide readers with clarity about the illness — with an entire chapter devoted to the vaccine response. The book also contains testimonials from patients and other doctors, research studies, news clippings, a letter they wrote to congress and a national COVID plan that can be adapted for future pandemics.
“Instead of the vaccine, people should have been treated early in the illness, and then they would have developed strong immunity, and we wouldn’t have all these new variants,” Dr. Fareed added.
About the Authors
Dr. George Fareed graduated from Harvard Medical School with Honors and completed a medical internship at Peter Bent Brigham Hospital. He has worked at NIAID, at Harvard Medical School and at UCLA School of Medicine.
He was a founder and director of scientific planning of a biotech company, Ingene (International Genetic Engineering, Inc.). Since 1991, Dr. Fareed has worked clinically in primary medical care in the Imperial Valley of California. He has been on the frontline for early COVID-19 treatment, and has practiced the whole spectrum of COVID-19 care, treating outpatients as well as inpatients as a hospitalist. He testified on November 19, 2020, in the Senate Hearing on early COVID-19 treatment.
Dr. Brian Tyson is a board-certified family practitioner who worked as an emergency physician at Arrowhead Regional Medical center for 13 years and as a hospitalist physician for 14 years before opening his own urgent care in 2018.
Dr. Tyson was the Program Medical Director for Cogent Healthcare and Beaver Medical Group. His experience with COVID-19 has been exceptional, with over 30,000 patients evaluated, and zero deaths with early treatment.
His urgent care serves a high-risk population that includes two nursing homes, and his success was due to his aggressive early management. Due to his proven methodology, Dr. Tyson is considered a frontline COVID-19 treatment expert and has been featured on multiple media sites.
For more information, please visit www.overcomingcoviddarkness.com.